cGAS–STING signalling in cancer: striking a balance with chromosomal instability
Biochemical Society Transactions · 26.04.2023 · 51 (2) · 539-555
DOI: 10.1042/bst20220838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, online erschienen am 06.03.2023. Verfasst von Bruno Beernaert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K. Hauptthemen laut MEDLINE: Chromosomal Instability, Neoplasms. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Cancer Research UK.
Abstract (Originalsprache)
Chromosomal instability (CIN) is a hallmark of cancer that drives tumour evolution. It is now recognised that CIN in cancer leads to the constitutive production of misplaced DNA in the form of micronuclei and chromatin bridges. These structures are detected by the nucleic acid sensor cGAS, leading to the production of the second messenger 2′3′-cGAMP and activation of the critical hub of innate immune signalling STING. Activation of this immune pathway should instigate the influx and activation of immune cells, resulting in the eradication of cancer cells. That this does not universally occur in the context of CIN remains an unanswered paradox in cancer. Instead, CIN-high cancers are notably adept at immune evasion and are highly metastatic with typically poor outcomes. In this review, we discuss the diverse facets of the cGAS–STING signalling pathway, including emerging roles in homeostatic processes and their intersection with genome stability regulation, its role as a driver of chronic pro-tumour inflammation, and crosstalk with the tumour microenvironment, which may collectively underlie its apparent maintenance in cancers. A better understanding of the mechanisms whereby this immune surveillance pathway is commandeered by chromosomally unstable cancers is critical to the identification of new vulnerabilities for therapeutic exploitation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, University of Oxford, Old Road Campus Research Building, Oxford OX3 7DQ, U.K.
ORCID-Profile: Bruno Beernaert, Eileen E Parkes
Förderung
- Wellcome Trust
- Cancer Research UK
Zitieren
APA
Beernaert, B., & Parkes, E. E. (2023). cGAS–STING signalling in cancer: striking a balance with chromosomal instability. Biochemical Society Transactions, 51(2), 539-555. https://doi.org/10.1042/bst20220838
Vancouver
Beernaert B, Parkes EE. cGAS–STING signalling in cancer: striking a balance with chromosomal instability. Biochemical Society Transactions. 2023;51(2):539-555. doi:10.1042/bst20220838
BibTeX
@article{Beernaert2023,
author = {Beernaert, Bruno and Parkes, Eileen E},
title = {cGAS–STING signalling in cancer: striking a balance with chromosomal instability},
journal = {Biochemical Society Transactions},
year = {2023},
volume = {51},
number = {2},
pages = {539--555},
doi = {10.1042/bst20220838}
}
EUVIMED